|
|
|
European Biopharmaceutical Review
|
| Estimated at about $6 billion annually, the current worldwide market for vaccines centres around a list of old enemies such as tuberculosis, typhoid, cholera, tetanus, diphtheria, rabies, smallpox, yellow fever and polio. Newer vaccines have been created for chickenpox, Hepatitis B and A, influenza and pneumonia. Today, with the power of genomics, proteomics and systems biology at our fingertips, we've entered into what many believe will be a golden age for prophylactic approaches. Enter the era of 'super vaccines' -vaccines that will mitigate everything from herpes, to cancers and even AIDS. Some of them will be tailor-made to fit the individual's genetic profile. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
10th-Anniversary Event RFID Journal LIVE! 2012
3-5 April 2012, Walt Disney World Swan and Dolphin Resort, Orlando, Florida
RFID Journal LIVE! 2012, our tenth annual conference and exhibition, is the only event where you can learn how to use RFID technologies to improve your pharmaceutical and medical packaging business, from real-world case studies across all applications, including asset tracking, logistics and transportation, supply chain management, warehouse and inventory management, security and more. Learn from a customized program featuring more than 50 end-user case studies and 8 industry-specific and how-to conference tracks.
More info >> |
|
 |
News and Press Releases |
 |
Increasing employer brand – the key to successful recruitment for engineering SMEs
Cheadle based industrial automation specialist SolutionsPT has appointed Louise Potts as People and Culture Manager. Potts will be focusing on increasing the company’s employer brand and achieving Best Companies and Investors in People accreditation for 2012.
More info >> |
|
|
